$9.75−0.27 (−2.69%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD
Bicara Therapeutics (BCAX) Institutional Ownership
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
Sources Ownership filingsHow we compute thisNot investment advice
No institutional 13F summary in the feed.
Insider trades · latest filings (Form 4)routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | Cohlhepp Ryan | President, COO & Interim CEO | Acquired · Option exercise | 17,500 | $3.79 | ↗ |
| Sep 8, 2026 | Cohlhepp Ryan | President, COO & Interim CEO | Disposed · Open-market sale | 14,058 | $22.77 | ↗ |
| Sep 8, 2026 | Cohlhepp Ryan | President, COO & Interim CEO | Disposed · Open-market sale | 3,442 | $23.43 | ↗ |
| Sep 8, 2026 | Cohlhepp Ryan | President, COO & Interim CEO | Disposed · Option exercise | 17,500Stock Option (Right to Buy) | — | ↗ |
| Aug 12, 2026 | Larson Jennifer | Chief Financial Officer | Acquired · Grant / award | 285,000Stock Option (Right to Buy) | — | ↗ |
| Aug 10, 2026 | Hyep Ivan | Chief Financial Officer | Acquired · Option exercise | 12,500 | $3.79 | ↗ |
| Aug 10, 2026 | Hyep Ivan | Chief Financial Officer | Disposed · Open-market sale | 12,500 | $27.97 | ↗ |
| Aug 10, 2026 | Hyep Ivan | Chief Financial Officer | Disposed · Option exercise | 12,500Stock Option (Right to Buy) | — | ↗ |
| Aug 10, 2026 | Mazumdar Claire | Chief Executive Officer | Acquired · Option exercise | 10,000 | $3.79 | ↗ |
| Aug 10, 2026 | Mazumdar Claire | Chief Executive Officer | Disposed · Open-market sale | 10,000 | $27.98 | ↗ |
| Aug 10, 2026 | Mazumdar Claire | Chief Executive Officer | Disposed · Option exercise | 10,000Stock Option (Right to Buy) | — | ↗ |
| Aug 10, 2026 | Cohlhepp Ryan | President and COO | Acquired · Option exercise | 18,750 | $3.79 | ↗ |
| Aug 10, 2026 | Cohlhepp Ryan | President and COO | Disposed · Open-market sale | 18,750 | $27.98 | ↗ |
| Aug 10, 2026 | Cohlhepp Ryan | President and COO | Disposed · Option exercise | 18,750Stock Option (Right to Buy) | — | ↗ |
| Jul 28, 2026 | Bender Jeremy | director | Acquired · Grant / award | 38,950Stock Option (Right to Buy) | — | ↗ |
| Jul 28, 2026 | Oliger Christy J. | director | Acquired · Grant / award | 38,950Stock Option (Right to Buy) | — | ↗ |
| Jul 10, 2026 | Mazumdar Claire | Chief Executive Officer | Acquired · Option exercise | 10,000 | $3.79 | ↗ |
| Jul 10, 2026 | Mazumdar Claire | Chief Executive Officer | Disposed · Open-market sale | 9,972 | $28.42 | ↗ |
| Jul 10, 2026 | Mazumdar Claire | Chief Executive Officer | Disposed · Open-market sale | 28 | $29.68 | ↗ |
| Jul 10, 2026 | Mazumdar Claire | Chief Executive Officer | Disposed · Option exercise | 10,000Stock Option (Right to Buy) | — | ↗ |
13F holdings are reported quarterly; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Not investment advice.

